Purpose: To examine the frequency of recurrence and identify risk factors for recurrence in patients with acute anterior uveitis (AAU).
Design: Retrospective cohort study from a single tertiary ophthalmic clinical center.
Participants: All subjects with AAU identified from a database of Inflammatory Eye Disease presenting to Te Whatu Ora (Auckland, New Zealand) between 2008 and 2021.
Purpose: To identify rates of uveitis reactivation both before and after the coronavirus disease (COVID) 2019 vaccine in subjects with a previous diagnosis of uveitis.
Design: Retrospective study.
Participants: Subjects were identified from the Inflammatory Eye Disease Registry at Auckland District Health Board diagnosed with uveitis between January 1, 2010, and December 31, 2020.
Background: Few studies have evaluated corneal crosslinking (CXL) in a prospective, randomised fashion. This study aimed to determine the efficacy and safety of CXL to reduce the progression of keratoconus.
Methods: Prospective, unmasked, randomised, contralateral eye controlled trial at a tertiary eye centre.
Purpose: To analyze corneal haze after corneal collagen crosslinking (CXL) for progressive keratoconus using Scheimpflug densitometry.
Setting: Auckland District Health Board, Auckland, New Zealand.
Design: Prospective randomized controlled study.
Purpose: Mutations in the zinc finger protein gene ZNF469 cause recessive brittle cornea syndrome, characterized by spontaneous corneal perforations. Genome-wide association studies (GWAS) have implicated common variants in this gene as a determinant for central corneal thickness (CCT). We investigated the contribution of ZNF469 in a sample set of keratoconus patients.
View Article and Find Full Text PDFPurpose: To use in vivo confocal microscopy (IVCM) to quantitatively analyze microstructural changes over time, after corneal collagen cross-linking for keratoconus.
Design: Prospective cohort study.
Participants: A total of 38 eyes of 38 patients undergoing collagen cross-linking for keratoconus.
Purpose: Mutations in the visual system homeobox 1 (VSX1) gene have been described at a low frequency in keratoconus and posterior polymorphous corneal dystrophy (PPCD). The putative role is controversial for several reasons, including a lack of mutations detected in other population cohorts. This study aims to determine whether VSX1 contributes to the genetic pathogenesis of keratoconus and PPCD in a New Zealand population, and includes analysis of a Polynesian population.
View Article and Find Full Text PDFBackground: The aim was to identify potential factors associated with acute corneal hydrops in a New Zealand population with keratoconus referred to a hospital eye service.
Methods: In a single hospital centre, in a retrospective review, demographic and clinical features of subjects with keratoconus and corneal hydrops over a 17-year period were compared with an age- and gender-matched control group of subjects with keratoconus but no history of corneal hydrops.
Results: One hundred and one eyes of 101 subjects (mean age 24.
Purpose: In corneal refractive surgery, postoperative ectasia risk assessment routinely includes pachymetric analysis at the apex and thinnest point. We examined whether these data differ worldwide and constructed preliminary country-specific normative thresholds.
Design: This was a multicenter, cross-sectional study.
Purpose: To compare intraocular pressure (IOP) measurements after penetrating keratoplasty (PK) using Goldmann applanation tonometry (GAT; Haag-Streit USA), TonoPen XL (Reichert Inc), Pascal Dynamic Contour tonometer (PDCT; Swiss Microtechnology AG), and Ocular Response Analyzer (ORA; Reichert Inc) and to analyze effects and correlation of corneal thickness and curvature on these measurements.
Design: Prospective, cross-sectional study.
Settings: Departments of Ophthalmology, University of Auckland and Auckland District Health Board, New Zealand.
Purpose: To evaluate corneal tomographic features of keratoconus and associations between risk factors and disease phenotype in New Zealand.
Setting: Departments of Ophthalmology, University of Auckland and Auckland District Health Board, Auckland, New Zealand.
Design: Clinic-based, cross-sectional study.